Treatment of Obesity in Children and Adolescents
Authors:
- 1 August 2012
- journal article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 17 (1) , 45-57
Abstract
The prevalence of childhood and adolescent obesity continues to rise in the United States (US). Immediate health consequences are being observed, and long-term risks are mounting within the pediatric population, secondary to obesity. The hallmark of prevention and treatment of obesity in children and adolescents includes lifestyle modification (i.e., dietary modification, increased physical activity, and behavioral modifications). However, when intensive lifestyle modification is insufficient to reach weight loss goals, adjunctive pharmacotherapy is recommended. Among the group of weight-loss medications, orlistat is the only US Food and Drug Administration (FDA)-approved prescription drug for the treatment of overweight and obese adolescents. Other medications, including metformin, need larger studies to establish their role in treatment. No single approach to management of pediatric obesity is the answer, given the complexity of the disorder and the many reasons for failure. Evidence of weight loss medications in addition to lifestyle modification supports short-term efficacy for treatment of obese children and adolescents, although long-term results remain unclear.Keywords
This publication has 64 references indexed in Scilit:
- Effects of Metformin on Body Weight and Body Composition in Obese Insulin-Resistant ChildrenDiabetes, 2011
- Metformin Extended Release Treatment of Adolescent ObesityArchives of Pediatrics & Adolescent Medicine, 2010
- Addition of Metformin to a Lifestyle Modification Program in Adolescents with Insulin ResistanceThe Journal of Pediatrics, 2008
- Childhood Obesity Predicts Adult Metabolic Syndrome: The Fels Longitudinal StudyThe Journal of Pediatrics, 2008
- Insulin Dynamics Predict Body Mass Index and Z-Score Response to Insulin Suppression or Sensitization Pharmacotherapy in Obese ChildrenThe Journal of Pediatrics, 2006
- Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndromeThe Journal of Pediatrics, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Heart-Rate Recovery Immediately after Exercise as a Predictor of MortalityNew England Journal of Medicine, 1999
- The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Absorption of Vitamins A and E in Healthy VolunteersThe Journal of Clinical Pharmacology, 1996
- Growth Hormone Secretion and Effects of Growth Hormone Therapy on Growth Velocity and Weight Gain in Children with Prader-Willi SyndromeJournal of Pediatric Endocrinology and Metabolism, 1996